Trial Profile
Fluvastatin in the therapy of acute coronary syndrome
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Fluvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms FACS
- 29 Oct 2005 New trial record.